#VoluntaryScheme

"The Bill establishes a #voluntaryscheme allowing #employers with unpaid levy liabilities 2 enter payment arrgmt of up to 6 yrs, with the final 20% of hist debts waived once 80% is paid.
This effectively rewards employers for systemat failing to pay workers the #LSL entitlements." #auspol #CoalLSL

VPAG payment rate for newer medicines will be 14.5% in 2026 The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5 pe...

#ABPI #pharma #VPAG #VPAG1 #LifeSciences #Medicinessales #Pharmasales #StatutoryScheme #VoluntaryScheme #VPAGpaymentrate #VoluntarySchemeforBrandedMedicinesPricingandAccess #NHS #UKlifesciencecompetitiveness #NHSadoption #costeffectivemedicines #UKlifesciencesinvestment
zurl.co/5G14Z

Companies granted third extension to VPAG 2026 decision deadline – now set for 16 December The ABPI and the government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, acce...

#ABPI #pharma #pharmaceuticals #PharmaceuticalCompanies #VPAG2026 #UKgovernment #voluntaryschemeforbrandedmedicinespricingaccessandgrowth #VPAGscheme #lifesciencessector #StatutorySchemeforbrandedmedicines #brandedpharmaceuticals #VPAG #VPAG1 #VoluntaryScheme #VoluntarySchemeNews
zurl.co/lJJaE

Companies granted further extension to VPAG 2026 decision deadline The ABPI and the government have agreed to a further two-week extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pric...

#ABPI #pharmaceuticalindustry #pharmaindustry #UKpharmaindustry #VPAG2026 #UKgovernment #2024VPAG #voluntaryschemeforbrandedmedicinespricingaccessandgrowth #VPAG #VPAGscheme #lifesciencessector #StatutorySchemeforbrandedmedicines #StatutoryScheme #VPAG #VoluntaryScheme
zurl.co/P95JM

UK doubles statutory payment rate on pharmaceutical sales from July The UK government has doubled the rate that pharmaceutical companies must repay on the sales of newer products to the NHS under the statutory scheme for branded medicines in the second half of 2025, t...

#ABPI #spendingreview #StatutoryScheme #VoluntaryScheme #VPAG #pharmaceuticalsales #UKgovernment #pharmaceuticalcompanies #NHS #brandedmedicines #NHSsales #healthcarebudget #healthcarespending #pharmaindustryinvestment #UK #VPAGreview #lifescienceinvestments
www.abpi.org.uk/media/news/2...